OPK OPKO Corp: רווח נקי למניה בארבעת הרבעונים האחרונים

OPKO Health, Inc. (OPK) net income is based on BioReference optimization and payments from Pfizer, with the parameter value equal to 18.80. Comparable annual EPS TTM growth on the GURU.Markets chart visualizes financial stability. However, low margins on genetic tests and geopolitical barriers in reagent logistics create serious risks for the company's global contracts.
OPK (OPKO Health Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Year-over-year (YoY) EPS growth (TTM) measures the dynamics of net income per share over a rolling twelve-month period, allowing for an assessment of business scaling efficiency and the pace of value generation. By analyzing the current EPS TTM YoY growth rate, an investor can see the impact of operational leverage at OPKO Health, Inc. (OPK), where laboratory automation and high-margin licensing payments transform volume growth into accelerated profit.